Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 108
of 6Next
1:

A phase 1 trial of nebulised heparin in acute lung injury.

Dixon B, Santamaria JD, Campbell DJ.

Crit Care. 2008;12(3):R64. Epub 2008 May 6.

PMID: 18460218 [PubMed - indexed for MEDLINE]

2:

Recombinant hirudin as a periprocedural antithrombotic in coronary angioplasty for unstable angina pectoris.

Hafner G, Rupprecht HJ, Luz M, Terres W, Schindel F, Friesen HJ, Heinrichs H, Jessel A, Meyer J, Prellwitz W.

Eur Heart J. 1996 Aug;17(8):1207-15.

PMID: 8869862 [PubMed - indexed for MEDLINE]

3:

Course of thrombin activation markers in patients implanted with Palmaz-Schatz stents: first experiences with a post-interventional anticoagulation regimen.

Haushofer A, Halbmayer WM, Dittel M, Prachar H, Mlczoch J, Fischer M.

Blood Coagul Fibrinolysis. 1994 Oct;5(5):697-706.

PMID: 7865675 [PubMed - indexed for MEDLINE]

4:

Anticoagulant therapy in acute lung injury.

Laterre PF, Wittebole X, Dhainaut JF.

Crit Care Med. 2003 Apr;31(4 Suppl):S329-36. Review.

PMID: 12682461 [PubMed - indexed for MEDLINE]

5:

Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.

Becker RC, Cannon CP, Tracy RP, Thompson B, Bovill EG, Desvigne-Nickens P, Randall AM, Knatternud G, Braunwald E.

Am Heart J. 1996 Mar;131(3):421-33. Review.

PMID: 8604620 [PubMed - indexed for MEDLINE]

6:

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group.

Abraham E, Baughman R, Fletcher E, Heard S, Lamberti J, Levy H, Nelson L, Rumbak M, Steingrub J, Taylor J, Park YC, Hynds JM, Freitag J.

Crit Care Med. 1999 Aug;27(8):1478-85.

PMID: 10470753 [PubMed - indexed for MEDLINE]

7:

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

Levine MN, Hirsh J, Gent M, Turpie AG, Cruickshank M, Weitz J, Anderson D, Johnson M.

Arch Intern Med. 1994 Jan 10;154(1):49-56.

PMID: 8267489 [PubMed - indexed for MEDLINE]

8:

Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.

Harenberg J, Stehle G, Blauth M, Huck K, Mall K, Heene DL.

Semin Thromb Hemost. 1997;23(1):83-90.

PMID: 9156415 [PubMed - indexed for MEDLINE]

9:

Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.

Kearon C, Harrison L, Crowther M, Ginsberg JS.

Thromb Res. 2000 Mar 15;97(6):395-403.

PMID: 10704648 [PubMed - indexed for MEDLINE]

10:

Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.

Gaussem P, Dubar M, le Bonniec B, Richard-Lordereau I, Jochemsen R, Aiach M.

Br J Clin Pharmacol. 2002 Feb;53(2):147-54.

PMID: 11851638 [PubMed - indexed for MEDLINE]

11:

The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.

Despotis GJ, Joist JH, Hogue CW Jr, Alsoufiev A, Kater K, Goodnough LT, Santoro SA, Spitznagel E, Rosenblum M, Lappas DG.

J Thorac Cardiovasc Surg. 1995 Jul;110(1):46-54.

PMID: 7609568 [PubMed - indexed for MEDLINE]

12:

Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.

Meduri GU, Tolley EA, Chinn A, Stentz F, Postlethwaite A.

Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1432-41.

PMID: 9817690 [PubMed - indexed for MEDLINE]

13:

Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.

Harenberg J, Malsch R, Angelescu M, Lange C, Michaelis HC, Wolf H, Heene DL.

Blood Coagul Fibrinolysis. 1996 Jun;7(4):477-83.

PMID: 8840001 [PubMed - indexed for MEDLINE]

14:

Activated clotting time differential is a superior method of monitoring anticoagulation following coronary angioplasty.

Pitney MR, Kelly SA, Allan RM, Giles RW, McCredie M, Walsh WF.

Cathet Cardiovasc Diagn. 1996 Feb;37(2):145-50.

PMID: 8808069 [PubMed - indexed for MEDLINE]

15:

Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.

Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.

Eur Heart J. 2000 Sep;21(17):1473-81.

PMID: 10952840 [PubMed - indexed for MEDLINE]

16:

Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits.

Aldea GS, O'Gara P, Shapira OM, Treanor P, Osman A, Patalis E, Arkin C, Diamond R, Babikian V, Lazar HL, Shemin RJ.

Ann Thorac Surg. 1998 Feb;65(2):425-33.

PMID: 9485240 [PubMed - indexed for MEDLINE]

17:

Heparin dosing and therapeutic activated partial thromboplastin times (aPTT) in acute coronary syndrome (ACS).

Westaway KP, Cruickshank M.

Aust Crit Care. 2006 Feb;19(1):6-8, 10-4.

PMID: 16544673 [PubMed - indexed for MEDLINE]

18:

A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.

Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD.

Crit Care Med. 1999 Oct;27(10):2224-8.

PMID: 10548211 [PubMed - indexed for MEDLINE]

19:

The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.

Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF.

J Am Coll Cardiol. 2003 Feb 5;41(3):394-402.

PMID: 12575965 [PubMed - indexed for MEDLINE]

20:

Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects.

Swan SK, St Peter JV, Lambrecht LJ, Hursting MJ.

Pharmacotherapy. 2000 Jul;20(7):756-70.

PMID: 10907966 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 108
of 6Next